Whole blood heparin concentrations do not correlate with plasma antifactor Xa heparin concentrations in pediatric patients undergoing cardiopulmonary bypass

Abstract

This study was designed to test the validity of whole blood heparin concentration (WHBC) measurements using an on-site protamine titration assay with the Hepcon instrument (Medtronic Blood Management, Parker, CO, USA) in pediatric patients less than 1 year old undergoing cardiopulmonary bypass (CPB). The validity of the Hepcon measurements was examined via a test of correlation with the gold standard plasma antifactor Xa activity (anti-Xa) assay. Fifty-one patients (23 females and 28 males) under 1 year old (mean age 5.3 months) were studied prospectively. Blood samples were taken at 5 min into CPB and at the end of CPB for the WBHC, plasma anti-Xa activity, and hematocrit (Hct). The WBHC was converted to plasma heparin level using a formula taking into account the collection of blood into citrate solution and the effect of the citrate on the hematocrit.

While a nonparametric statistical analysis revealed that the mean corrected values from the Hepcon instrument were not significantly different from the mean anti-Xa values (p = 0.070 at 5 min on CPB, p = 0.518 at the end of CPB), there was no significant correlation between these values at either 5 min into CPB (r = 0.113, p = 0.429) or at the end of CPB (r = -0.247, p = 0.080). The lack of correlation between the two assays may be related to the extreme hemodilution observed during CPB in small children, which leads to very low concentrations of coagulation proteins. Due to this discrepancy, whole blood heparin monitors should be further evaluated in children undergoing CPB.

Get full access to this article

View all access options for this article.

References

Bull BS , Korpman RA , Huse WM , Briggs BD. Heparin therapy during extracorporeal circulation. I. Problems inherent in existing heparin protocols . J Thorac Cardiovasc Surg 1975; 69: 674-684 .

Bull BS , Huse WM , Brauer FS , Korpman RA. Heparin therapy during extracorporeal circulation. II. The use of a dose-response curve to individualize heparin and protamine dosage . J Thorac Cardiovasc Surg 1975; 69: 685-688 .

Hattersley P. Activated coagulation time of whole blood . JAMA 1966; 196: 150-154 .

Moorehead MT , Westengard JC , Bull BS. Platelet involvement in the activated coagulation time of heparinized blood . Anesth Analg 1984; 63: 394-398 .

Culliford AT , Gitel SN , Starr N et al. Lack of correlation between activated clotting time and plasma heparin during cardiopulmonary bypass . Ann Surg 1980; 193: 105-111 .

Despotis GJ , Summerfield AL , Joist JH et al. Comparison of activated coagulation time and whole blood heparin measurements with laboratory plasma anti-Xa heparin concentration in patients having cardiac operations . J Thorac Cardiovasc Surg 1994; 108: 1076-1082 .

Andrew M , MacIntyre B , Williams W et al. Heparin therapy during cardiopulmonary bypass in children requires ongoing quality control . Thromb Haemostas 1993; 70: 937-941 .

Reich DL. Monitoring hemostasis in the perioperative period: anticoagulation control . J Cardiothorac Vasc Anesth 1991; 5: 4-7 .

Despotis GJ , Santoro SA , Spitznagel E et al. Prospective evaluation and clinical utility of on-site monitoring of coagulation in patients undergoing cardiac operation . J Thorac Cardiovasc Surg 1994; 107: 271-279 .

10.

DeLaria GA , Tyner JJ , Hayes CL , Armstrong BW. Heparin-protamine mismatch. A controllable factor in bleeding after open heart surgery . Arch Surg 1994; 129: 944-950 .

11.

Andrew M , Paes B , Milner R , Johnston M et al. Development of the human coagulation system in the full-term infant . Blood 1987; 70: 165-172 .

12.

Andrew M , Paes B , Milner R et al. Development of the human coagulation system in the healthy premature infant . Blood 1988; 72: 1651-1657 .

13.

Andrew M , Vegh P , Johnston M , Bowker J , Ofosu F , Mitchell L. Maturation of the haemostatic system during childhood . Blood 1992; 80: 1998-2005 .

14.

Gruenwald C , Andrew M , Burrows F , Williams W. Cardiopulmonary bypass in the neonate. Advances in cardiac surgery, 4th edn. St Louis, MO: Mosby-Year Book , 1993: 137-156.

15.

Mann KG , Butenas S , van’t Veer C. ‘Normal’ hemostasis [Abstract] . Blood 1998; 92.

16.

Chan A , Leaker M , Burrows F et al. Coagulation profile of paediatric patients undergoing cardiopulmonary bypass . Thromb Haemostas 1997; 77: 270-277 .